TABLE 6.

Infection stratified by dexamethasone use, among inpatients who received supplementary oxygen

	Did not receive, n (%)	Received dexamethasone, n (%)	P
n	24	24
Days 0–7 total infections	5 (20.8)	12 (50.0)	0.069
Days 8–30 total infections	1 (4.2)	6 (25.0)	0.097
Days 8–30 bacterial	1 (4.2)	4 (16.7)	0.35
Days 8–30 viral	0 (0.0)	2 (8.3)	0.49
Days 8–30 fungal	0 (0.0)	1 (4.2)	1.0
Days 31–60 total infections			0.23
None	24 (100)	21 (87.5)
Yes	0 (0.0)	2 (8.3)
N/A	0 (0.0)	1 (4.2)
Days 31–60 bacterial			0.5
None	24 (100)	22 (91.7)
Yes	0 (0.0)	1 (4.2)
N/A	0 (0.0)	1 (4.2)
Days 31–60 viral			0.5
None	24 (100)	22 (91.7)
Yes	0 (0.0)	1 (4.2)
N/A	0 (0.0)	1 (4.2)
Days 31–60 fungal			N/A
None	24 (100)	23 (95.8)
N/A	0 (0.0)	1 (4.2)
Days 61–90 total infections			0.5
None	24 (100)	22 (91.7)
Yes	0 (0.0)	1 (4.2)
N/A	0 (0.0)	1 (4.2)
Days 61–90 bacterial			0.5
None	24 (100)	22 (91.7)
Yes	0 (0.0)	1 (4.2)
N/A	0 (0.0)	1 (4.2)
Days 61–90 viral			N/A
None	24 (100)	23 (95.8)
N/A	0 (0.0)	1 (4.2)
Days 61–90 fungal			0.5
None	24 (100)	22 (91.7)
Yes	0 (0.0)	1 (4.2)
N/A	0 (0.0)	1 (4.2)
Any infection after 7th day  of admission	1 (4.2)	6 (25.0)	0.097

N/A, not applicable.